Hackensack Meridian School of Medicine

Hackensack Meridian Health Research Institute Creates First Spin-off Company, EValuate Diagnostics

Retrieved on: 
Wednesday, October 4, 2023
Hackensack Meridian Health, CDI, Commercialization, Evaluation, Neoplasm, Infection, Cancer, Hackensack Meridian School of Medicine, Breast, Medicine, Research, Biomarker, RNA, Lung, Science, EVS, Bear, Discovery, Seminal vesicles, Prostate Cancer Foundation, Patient, Physician, Blood, FACS, Den, Exosome, Health, Laboratory, Disease, Medical imaging, Pharmaceutical industry, Innovation, Urology

EDISON, N.J., Oct. 4, 2023 /PRNewswire/ -- The Hackensack Meridian Health Research Institute and its Office of Innovation and Commercialization have taken the step of establishing the first spin-off company based on science developed within the Hackensack Meridian Health network. The company aims to make tests detecting cancer and other diseases earlier than ever before.

Key Points: 
  • "This is a remarkable breakthrough for our health network, and for patients of the future," said Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health.
  • "We are taking the science produced by our terrific minds at the Hackensack Meridian Health Research Institute, and then moving it to the market so it can benefit all.
  • "This is a new milestone for innovation at Hackensack Meridian Health," said Ihor Sawczuk, M.D., FACS, Hackensack Meridian Health's president of Academics, Research and Innovation, founding chair of the Hackensack Meridian Health Research Institute, and also associate dean of Clinical Integration and professor and chair emeritus of Urology at the Hackensack Meridian School of Medicine.
  • The Office of Innovation and Commercialization launched in 2022 and promises to support innovations and discoveries across Hackensack Meridian Health.

Hackensack Meridian Health CEO Robert C. Garrett Ranked No. 1 in CEO Forum's 10 CEOs Transforming Healthcare in America

Retrieved on: 
Wednesday, July 5, 2023
Housing, Hackensack Meridian Health, Student, Curriculum, Health equity, Hackensack Meridian School of Medicine, Dana–Farber Cancer Institute, American Medical Association, School, Jefferson Health, Patient, Physician, Health, Food, Human Dimension, Nursing

EDISON, N.J., July 5, 2023 /PRNewswire/ -- Hackensack Meridian Health, New Jersey's largest and most integrated health network, is proud to announce that CEO Robert C. Garrett is ranked No. 1 in the prestigious CEO Forum's 10 CEOs Transforming Healthcare'' in the U.S. for the third year in a row.

Key Points: 
  • EDISON, N.J., July 5, 2023 /PRNewswire/ -- Hackensack Meridian Health, New Jersey's largest and most integrated health network, is proud to announce that CEO Robert C. Garrett is ranked No.
  • 1 in the prestigious CEO Forum's 10 CEOs Transforming Healthcare'' in the U.S. for the third year in a row.
  • By viewing healthcare through a broader lens, including non-medical issues, we add a human dimension to the training of future physicians.
  • "Every person in this nation should have equal access to high-quality healthcare providers and be given all the tools necessary to achieve optimal health," Mr. Garrett said.

Hackensack Meridian Health Partners with Neosoma for Innovation in Brain Tumor Treatment, Research

Retrieved on: 
Friday, February 24, 2023
Radiation, Hackensack Meridian School of Medicine, Neuro, Immunotherapy, Cancer, Brain, Artificial intelligence, Genomics, Magnetic resonance imaging, Hackensack Meridian Health, Research, Partnership, Software, Health, FDA, Patient, MRI, Innovation, Infection, HMH, Glioblastoma, Neurosurgery, Den, Food and Drug Administration, Bear, Communication, Food, FACS, Neoplasm, Physician, Medical imaging, Pharmaceutical industry, Nursing, Urology

EDISON, N.J., Feb. 24, 2023 /PRNewswire/ -- Hackensack Meridian Health and Neosoma, Inc., an innovative medical technology company focused on helping clinicians advance the treatment of brain cancers through the use of artificial intelligence (AI), announce a new strategic partnership to tackle some of the most difficult-to-treat tumors.

Key Points: 
  • "Partnering with Neosoma Inc. is a great way to continue to develop potential game changing therapies to treat these challenging cancers."
  • "We have a terrific partnership with Hackensack Meridian Health already," said Ken Kolodziej, the CEO and co-founder of Neosoma.
  • The technology produces precise and accurate brain tumor analysis on MRIs, providing physicians with critical insights to guide treatment decisions.
  • In clinical practice, the brain MRI is the physician's best tool to evaluate the details and changes in a brain tumor.

Hackensack Meridian School of Medicine Fully Accredited

Retrieved on: 
Wednesday, February 22, 2023
AAMC, Physician, Hackensack Meridian School of Medicine, AMA, Association of American Medical Colleges, American Medical Association, Student, Medicine, Social determinants of health in poverty, HMH, Medical education, Accreditation, LCME, Human, Workforce, Doctor of Philosophy, Determinant, Liaison Committee on Medical Education, Curriculum, Human Dimension, Heart, Liaison Committee, Faculty, School, Hackensack Meridian Health, MD, Nursing, Management, Health

NUTLEY, N.J., Feb. 22, 2023 /PRNewswire/ -- The Hackensack Meridian School of Medicine (HMSOM) has been granted full accreditation by the Liaison Committee on Medical Education (LCME), a major milestone capping a robust seven-year review process that affirms the highest standards in the training of future physicians. The school admitted its first class in 2018 and has graduated two classes, many of whom are serving residencies in Hackensack Meridian Health hospitals.

Key Points: 
  • The school admitted its first class in 2018 and has graduated two classes, many of whom are serving residencies in Hackensack Meridian Health hospitals.
  • "This is the culmination of years of work that started with a vision to reinvent medical education to create a physician workforce to thrive in a new state of medicine," said Robert C. Garrett, FACHE, chief executive officer of Hackensack Meridian Health.
  • The LCME is the accrediting body for all institutions conferring medical doctorate (MD) degrees in the United States and Canada.
  • "We have spent long hours making this dream become a reality," said Miriam Hoffman, M.D., a vice dean of the School.

ConnectWise wins two awards at the 37th Annual Cannata Report Awards and Charities Gala

Retrieved on: 
Wednesday, November 16, 2022
Growth, Organization, Satellite navigation, ConnectWise Control, Cannata, Data management, Hackensack Meridian School of Medicine, Charitable organization, Image Channel, Automation, Ecosystem, Documentation, Imaging, Filippo Cannata, Video game, Pharmaceutical industry

ConnectWise has been recognized for four years in our Annual Dealer Survey as a leading IT provider for several reasons.

Key Points: 
  • ConnectWise has been recognized for four years in our Annual Dealer Survey as a leading IT provider for several reasons.
  • Winners were announced at The Cannata Reports 37th Annual Awards & Charities Gala last week.
  • This year, The Cannata Reports Annual Awards & Charities Gala raised $180,000 to create the Marie Cusumano Endowed Scholarship at the Hackensack Meridian School of Medicine.
  • For the complete list of winners of The Cannata Reports 2022 Frank Awards and more info, visit https://www.thecannatareport.com/awards-charity/2022-frank-award-finalis... .

Sharp Receives Four Frank Awards at The Cannata Report's Annual Imaging Industry Event

Retrieved on: 
Monday, November 14, 2022
The Information (company), SEC, Josette Frank Award, Workflow, Technology, Hackensack Meridian School of Medicine, Companies listed on the Toronto Stock Exchange (A), SBS, Fortune, Madison Hotel (Atlantic City), Madison Hotel, Best, Software, Marketing, Second year, Industry, YouTube, The, Sharp Corporation, Electronics, Best Manufacturing Company, CEO, Smarter Planet, Solution, Management, Financial adviser, Public relations, Sharp, Facebook, Male

MONTVALE, N.J., Nov. 14, 2022 /PRNewswire/ -- Sharp Imaging and Information Company of America (SIICA), a division of Sharp Electronics Corporation (SEC), announces that it has been honored with four Frank Awards at The Cannata Report's 37th Annual Awards & Charities Gala, which took place on November 10, 2022, at The Madison Hotel in Morristown, NJ. For the fourth consecutive year, Sharp received Best Manufacturer and Best Male Executive – Mike Marusic. This is also the third year Sharp received the Best-in-Class award and the second consecutive year that the company was awarded the Best Marketing Strategy award.

Key Points: 
  • The Frank Awards honor business leaders from the manufacturer, financing and software and services segments of the imaging industry.
  • Winners are determined by The Cannata Report's Annual Dealer Survey, which gathers the views of the dealer community on topics that are important to their businesses.
  • "Sharp is firing on all cylinders in the dealer channel," said CJ Cannata, president and CEO, The Cannata Report.
  • The awards mark the fifth year in a row that Sharp has received three or more Frank Awards, bringing the total to 17 awards since 2018.

Frank Award Winners Announced at The Cannata Report's 37th Annual Awards & Charities Gala Benefitting Endowed Scholarship at Hackensack Meridian School of Medicine

Retrieved on: 
Friday, November 11, 2022
CEO, Paper, Student, Xerox, Multimedia, Shake It Up, DocuWare, After, Workforce, Frank, Security, Madison Hotel, Charitable organization, Cannata, National Kidney Foundation, First Citizens BancShares, Friends, ConnectWise Control, Hackensack Meridian Health, Organization, Hackensack Meridian School of Medicine, Veteran, Education, School, Josette Frank Award, 2011 Baseball Hall of Fame balloting, Madison Hotel (Atlantic City), Regional Network Development Plan, Intelligence, The, The Information (company), Physician, Gala, Thought, ACDI, Pharmaceutical industry, Auction, Management, Medicine

HAMBURG, N.J., Nov. 11, 2022 /PRNewswire/ -- The Cannata Report, the leading publication covering the independent dealer channel in the office technology industry, announced the winners of the Frank Awards at its 37th Annual Awards and Charities Gala, themed "Shake It Up," sponsored by Hytec Dealer Services and ConnectWise last night at The Madison Hotel in Morristown, NJ. The event raised $180,000 to create the Marie Cusumano Endowed Scholarship at Hackensack Meridian School of Medicine, located in Nutley, NJ. To date, The Cannata Report's Annual Awards & Charities Gala has raised $1.5 million for endeavors funded by Hackensack Meridian Health Foundation and has collectively raised over $3 million for many charitable organizations nationwide.

Key Points: 
  • The event raised $180,000 to create the Marie Cusumano Endowed Scholarship at Hackensack Meridian School of Medicine , located in Nutley, NJ.
  • To date,The Cannata Report's Annual Awards & Charities Galahas raised $1.5 million for endeavors funded by Hackensack Meridian Health Foundation and has collectively raised over $3 million for many charitable organizations nationwide.
  • Weiss is the first person to receive the award created last year to honor its namesake Frank G. Cannata, founder of The Cannata Report.
  • "Hackensack Meridian School of Medicine is committed to offering the best, most patient- andcommunity-centered medical education to our medical students," said Jeffrey Boscamp, M.D.,interim dean, Hackensack Meridian School of Medicine.

Genomic Testing Cooperative and its Co-Op Members First to Use Artificial Intelligence to Distinguish Between 45 Hematologic and Solid Neoplasms Using Targeted Transcriptome

Retrieved on: 
Thursday, October 13, 2022
Biotechnology, Health, Genetics, Technology, Artificial Intelligence, CA, Efficiency, Acute myeloid leukemia, Diagnosis, Follicular lymphoma, Chronic lymphocytic leukemia, Patient, Hackensack Meridian School of Medicine, RNA, Academy, Hodgkin lymphoma, Solutions Journalism Network, Artificial intelligence, Colorectal cancer, Precision medicine, B-cell lymphoma, Software, Lung cancer, LCA, Phylogenetic inference using transcriptomic data, The American Journal of Pathology, AI, CEO, American Journal, Breast cancer, GTC, Flow cytometry, Prognosis, Marie Cassidy, Immunohistochemistry, DNA, Acute lymphoblastic leukemia, DOI, Ovarian cancer, Biomarker, Algorithm, Medical device, Medical imaging, Elsevier, Oncology, Pathology

GTCs RNAnalysis algorithm is used to distinguish between 45 different diagnostic classes providing probability scores.

Key Points: 
  • GTCs RNAnalysis algorithm is used to distinguish between 45 different diagnostic classes providing probability scores.
  • When needed, TraceWork is used to distinguish between two diagnostic entities determined by RNAnalysis to be of similar high probability score.
  • Genomic Testing Cooperative (GTC) is a privately-owned molecular testing company located in Irvine, CA.
  • The company offers its patron members a full suite of comprehensive genomic profiling based mainly on next generation sequencing.

Seton Hall Hosts Virtual Solar Power Platform Hackathon with Microsoft and Solar Landscape, Registration is Free and Now Open

Retrieved on: 
Friday, October 7, 2022
Cloud, The Princeton Review, U.S. News & World Report, Illinois State University College of Arts and Sciences, Public utility, School, Seton Hall University, Electricity, Community engagement, Employment, Intelligence, Hackensack Meridian School of Medicine, Mentorship, Program, Medicine, Microsoft, Seton Hall University School of Law, Student, Hackensack Meridian Health, Technology, University, Catholic (term), Gold, Data science, IHS, Cloud computing, Hall, Microsoft Azure, Solar energy, Microsoft Power Platform, College, Temple of Azure Clouds, Nursing school, New Jersey Board of Public Utilities, Azure, Speech, Climate change, Heart, Public policy, Science Power Platform, Law school, Bloomberg Businessweek, Renewable energy, Management, Video game, Health

SOUTH ORANGE, N.J., Oct. 7, 2022 /PRNewswire-PRWeb/ -- Teams of students from Seton Hall and beyond are invited to participate in a Solar Power Platform Hackathon from October 21 – 23, a virtual event sponsored by Microsoft, Seton Hall University and Solar Landscape. Registration is now open and will close on Wednesday, October 15

Key Points: 
  • Seton Hall has partnered with Microsoft and Solar Landscape to give students the opportunity to learn and leverage Microsoft's services to analyze existing solar power coverage and propose expansions.
  • SOUTH ORANGE, N.J., Oct. 7, 2022 /PRNewswire-PRWeb/ -- Teams of students from Seton Hall and beyond are invited to participate in a Solar Power Platform Hackathon from October 21 23, a virtual event sponsored by Microsoft, Seton Hall University and Solar Landscape.
  • The program encourages installing solar facilities, which provide electricity at a lower cost to households than traditional fossil-fuel power plants, to serve communities across New Jersey.
  • "For developing apps, the students use the Microsoft Power Platform, a 'low-code' analytics and cloud computing platform that is accessible to individuals without programming backgrounds.

Practice Changing Study Highlights Value of Starting Immunotherapy Before Targeted Therapies in Patients with BRAF-Mutated Melanoma

Retrieved on: 
Tuesday, October 4, 2022
DREAM, Nation, Cancer, MEK, Hospital, American Journal of Clinical Oncology, Melanoma, American Cancer Society, Mortality, NCI, Neoplasm, Physician, Ipilimumab, Immunotherapy, Survival, Research, Disease, New Jersey-New York 7 Conference, NCI-designated Cancer Center, Clinical trial, Hackensack Meridian Health, New, Multimedia, Protein, Nursing, BRAF, Patient, Progression-free survival, September 27, View, Annual report, Mutation, Immune system, MedStar Health, CI, Georgetown Lombardi Comprehensive Cancer Center, Hackensack Meridian School of Medicine, Strathcona County, Georgetown, Journal, Oncology, Nivolumab, Education, Aftercare, Diagnosis, MedSTAR, Dabrafenib, III, Pharmaceutical industry, Vaccine

Targeted medications and immunotherapy have become standard care for people with advanced melanoma.

Key Points: 
  • Targeted medications and immunotherapy have become standard care for people with advanced melanoma.
  • Starting in 2015, 265 patients with metastatic melanoma were randomly assigned to one of two groups.
  • One group started treatment with combination ipilimumab and nivolumab immunotherapy, and the second group began with the targeted therapies dabrafenib and trametinib.
  • Two-year overall survival was 72% among patients who received combination immunotherapy first versus 52% for those who took the two targeted therapies as initial treatment.